# LeMaitre Vascular Inc – FDA Inspection, Jul 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/8c4cfc21-1d71-416f-85d2-f20e082ddb4c
Source feed: FDA_Inspections

> FDA inspection 1061763 of LeMaitre Vascular Inc, July 11, 2018. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061763
- Company Name: LeMaitre Vascular Inc
- Inspection Date: 2018-07-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1202890 - 2023-03-29
- [FDA Inspection 963317 - 2016-03-01](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/62974030-97ec-455e-9f32-7b3bda73bb46)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/adam-j-taylor/a6e86ebd-4079-4c56-9129-8574e42ef75c)

Company: https://www.keypedia.com/companies/lemaitre-vascular-inc/aefe38d0-be3a-4088-a06d-fff4d1e4d063

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d